Reuters logo
2 个月前
BRIEF-Intellia Therapeutics and San Raffaele University and Research Hospital to combine CRISPR/cas9 genome editing with enhanced cell therapies
2017年6月6日 / 中午11点51分 / 2 个月前

BRIEF-Intellia Therapeutics and San Raffaele University and Research Hospital to combine CRISPR/cas9 genome editing with enhanced cell therapies

June 6 (Reuters) - Intellia Therapeutics Inc

* Intellia Therapeutics and San Raffaele University And Research Hospital to combine CRISPR/cas9 genome editing with enhanced cell therapies to fight cancer Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below